How to access Talvey from the UAE, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-23
An Emirati patient with relapsed or refractory multiple myeloma whose disease has progressed after multiple prior lines, including exposure to BCMA-directed therapies, may be evaluated by their haematologist for Talvey (talquetamab-tgvs). Talvey is FDA-approved, developed by Janssen (Johnson & Johnson), and is a GPRC5D×CD3 bispecific antibody. By targeting GPRC5D rather than BCMA, Talvey offers an alternative immunotherapy axis for patients whose myeloma has escaped BCMA-directed therapies or who need a non-BCMA option upfront. In the UAE, Talvey is not yet broadly registered, which is why your haematologist may be navigating a named-patient import pathway on your behalf.
This guide explains the pathway, what documentation your physician needs, typical timing and how quotes work, and where Reserve Meds fits in.
Ask about Talvey in UAE
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Talvey is administered subcutaneously on a step-up schedule to reduce cytokine release syndrome risk, small priming doses followed by a weekly or bi-weekly target dose. Step-up is typically conducted in an inpatient or closely monitored haematology unit; subsequent doses transition to outpatient dosing. Eligibility is based on prior line history, fitness for immune-engaging therapy, and access to a unit familiar with CRS, neurotoxicity, and GPRC5D-specific adverse-event patterns such as dysgeusia and dermatologic effects. Your haematologist will confirm eligibility and coordinate the step-up admission.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Is Talvey legally importable into the UAE?
Yes, through the UAE Ministry of Health and Prevention (MoHAP) named-patient import framework. Parallel authority operates in Abu Dhabi through the Department of Health (DoH) and in Dubai through Dubai Health Authority (DHA), depending on where the prescribing facility is located.
The named-patient mechanism allows an Emirati-licensed physician to import a medicine not locally registered when: (a) the medicine is approved by a recognised reference authority such as the US FDA, (b) no clinically equivalent locally registered alternative is suitable for the patient, (c) the physician takes clinical responsibility, and (d) the importing party documents chain of custody. For Talvey, a cold-chain biologic administered after a hospital-based step-up, most the UAE tertiary haematology units already have the infrastructure.
How the pathway works, step by step
- Consultation with your treating haematologist. Eligibility assessment including prior BCMA exposure where relevant, line history, and fitness for bispecific therapy.
- Haematology unit coordination. The admitting haematology unit confirms step-up admission capacity and CRS/neurotoxicity monitoring protocols.
- MoHAP named-patient application. Your physician or hospital pharmacy files the application with clinical rationale, patient reference, product details, and chain-of-custody plan.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner to secure product from authorised distribution.
- Cold-chain shipment. The product ships with continuous temperature monitoring and chain-of-custody documentation.
- Arrival, step-up admission, and ongoing dosing. The hospital pharmacy releases doses for the step-up admission and subsequent outpatient injections.
What documentation your physician needs
Your physician will typically need to provide:
- A clinical rationale letter confirming relapsed/refractory myeloma, line history (including prior BCMA exposure if applicable), and Talvey as the indicated treatment
- Verification of their UAE medical licence
- Identification of the admitting haematology unit and the CRS/neurotoxicity monitoring plan
- Patient identifier (anonymised reference where possible)
- Planned step-up schedule and transition to maintenance dosing
Reserve Meds provides a physician documentation kit that bundles the templates MoHAP reviewers expect to see, including the GPRC5D-specific adverse-event surveillance plan (dysgeusia, skin, nail changes).
Costs and timing
The cost of Talvey is driven by vial size and dosing frequency. Medicine price: quote on request. You get a written quote for your case before you commit. The initial step-up cycle typically includes inpatient monitoring costs locally. Cold-chain logistics, MoHAP documentation handling, and coordination add incremental cost. Reserve Meds issues a full transparent quote at the start of intake.
We give you a written timeline estimate for your case before you commit. Subsequent doses ship on a rolling basis against your dosing calendar.
If your clinical situation is time-sensitive, tell us at intake. We triage accordingly.
A culturally-aware note: Talvey commonly causes taste alteration and skin/nail changes. Families in the Gulf often prepare specific foods during illness as an expression of care; our team shares an orientation brief on practical dietary and skin-care adjustments that can help patients tolerate therapy better.
Reserve Meds's role
Reserve Meds is a US-based digital health company that coordinates access to cross-border specialty medicine. For Talvey specifically, we provide:
- Sourcing. Through our US-licensed pharmaceutical wholesale partner, operating under DSCSA chain-of-custody.
- Documentation. Regulatory package for your physician and for MoHAP review.
- Logistics. Cold-chain, temperature-monitored shipment coordination.
- Dedicated case lead. A named point of contact for your family and your physician through intake, step-up, and maintenance.
What we do not do: we are not the prescriber, we do not practise medicine, and we are not the dispensing pharmacy. All clinical decisions remain with your treating haematologist and the admitting unit.
Frequently asked
Is this legal in the UAE? Yes, when executed through the MoHAP (or DoH/DHA) named-patient framework with appropriate documentation. Cross-border named-patient import is a routine mechanism across the UAE haematology. See our trust and compliance page.
Why GPRC5D rather than BCMA? GPRC5D is a distinct target expressed on myeloma plasma cells. For patients who have already been exposed to BCMA-directed therapy (CAR-T or bispecifics) and whose disease has progressed, a non-BCMA target can restore a tumour-engagement axis. Your haematologist will explain sequencing.
How long is the inpatient step-up? The step-up admission length varies by centre and patient response. The UAE tertiary haematology units follow standing international protocols; your team will advise on expected length.
What about dysgeusia and skin effects? These are known features of the GPRC5D class and are typically manageable with supportive care. Your haematology team will guide you and your family.
Will private insurance cover this? Cash-pay is the default. Some UAE insurers consider named-patient imports case by case; we supply documentation for your submission but do not process insurance claims directly.
Next step
For Talvey coordination in the UAE, start your case at the portal or message us on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.
Composite case examples. This content is for general information and does not constitute medical advice.
Reviewed by the Reserve Meds clinical operations team. Last reviewed: 2026-04-23.
Abu Dhabi and Dubai
This guide covers the whole UAE, including Abu Dhabi and Dubai. At federal level, medicines are regulated by the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP). MOHAP also issues permits to import medicines for personal use. Hospitals, clinics and doctors are licensed by the health authority of their own emirate: the Department of Health Abu Dhabi (DoH) in Abu Dhabi, and the Dubai Health Authority (DHA) in Dubai.
In practice, the hospital that treats you follows the rules of its own emirate, so the paperwork is prepared for that hospital. Tell us which hospital or doctor is treating you, in Abu Dhabi, Dubai or another emirate, and we prepare the document pack for that route.
Sources: Department of Health Abu Dhabi; Dubai Health Authority, Health Regulation Sector; MOHAP, permit to import medicines for personal use; Simmons & Simmons, UAE pharmaceutical law and the Emirates Drug Establishment.
Frequently asked questions
How can I get Talvey in the UAE if it is not approved or available there?
Reserve Meds coordinates US-sourced Talvey for patients in the UAE through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for the UAE and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Talvey in the UAE through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Talvey. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in the UAE, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Talvey in the UAE through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Talvey to a patient in the UAE?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Talvey to your treating physician or hospital pharmacy in the UAE, with appropriate handling for the product.
How long does it take, and what does Talvey in the UAE cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Talvey in the UAE?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.